-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Overview on clinical trials in Waldenstroms macroglobulinemia
Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi & Enrica Morra
Clinical Trail Outcomes: Clinical Investigation
-
Overview on clinical trials in Waldenstroms macroglobulinemia
Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi & Enrica Morra
Clinical Trail Outcomes: Clinical Investigation
-
Overview on clinical trials in Waldenstroms macroglobulinemia
Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi & Enrica Morra
Clinical Trail Outcomes: Clinical Investigation
-
Overview on clinical trials in Waldenstroms macroglobulinemia
Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi & Enrica Morra
Clinical Trail Outcomes: Clinical Investigation
-
Overview on clinical trials in Waldenstroms macroglobulinemia
Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi & Enrica Morra
Clinical Trail Outcomes: Clinical Investigation
-
Overview on clinical trials in Waldenstroms macroglobulinemia
Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi & Enrica Morra
Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bevacizumab in the treatment of epithelial ovarian carcinoma
Brittany A Davidson & Angeles Alvarez Secord
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Biologic monotherapy for the treatment of rheumatoid arthritis
Andrew Taylor, Graeme Jones
Review Article: Clinical Investigation
-
Biologic monotherapy for the treatment of rheumatoid arthritis
Andrew Taylor, Graeme Jones
Review Article: Clinical Investigation
-
Biologic monotherapy for the treatment of rheumatoid arthritis
Andrew Taylor, Graeme Jones
Review Article: Clinical Investigation
-
Biologic monotherapy for the treatment of rheumatoid arthritis
Andrew Taylor, Graeme Jones
Review Article: Clinical Investigation
-
Biologic monotherapy for the treatment of rheumatoid arthritis
Andrew Taylor, Graeme Jones
Review Article: Clinical Investigation
-
Biologic monotherapy for the treatment of rheumatoid arthritis
Andrew Taylor, Graeme Jones
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation